129 related articles for article (PubMed ID: 12737333)
1. Treatment of reactive arthritis with infliximab.
Oili KS; Niinisalo H; Korpilähde T; Virolainen J
Scand J Rheumatol; 2003; 32(2):122-4. PubMed ID: 12737333
[TBL] [Abstract][Full Text] [Related]
2. Reactive Arthritis Caused by Yersinia enterocolitica Enteritis.
Honda K; Iwanaga N; Izumi Y; Tsuji Y; Kawahara C; Michitsuji T; Higashi S; Kawakami A; Migita K
Intern Med; 2017; 56(10):1239-1242. PubMed ID: 28502944
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
[TBL] [Abstract][Full Text] [Related]
5. Signalling profiles of circulating leucocytes in patients recovered from reactive arthritis.
Alanärä T; Aittomäki S; Kuuliala K; Kuuliala A; Siitonen S; Leirisalo-Repo M; Repo H
Scand J Rheumatol; 2012 Aug; 41(4):267-74. PubMed ID: 22651550
[TBL] [Abstract][Full Text] [Related]
6. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
Elkayam O; Bashkin A; Mandelboim M; Litinsky I; Comaheshter D; Levartovsky D; Mendelson E; Wigler I; Caspi D; Paran D
Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
[TBL] [Abstract][Full Text] [Related]
7. Infliximab in two patients with juvenile ankylosing spondylitis.
Schmeling H; Horneff G
Rheumatol Int; 2004 May; 24(3):173-6. PubMed ID: 14648110
[TBL] [Abstract][Full Text] [Related]
8. Spectacular evolution of reactive arthritis after early treatment with infliximab.
Thomas-Pohl M; Tissot A; Banal F; Lechevalier D
Joint Bone Spine; 2012 Oct; 79(5):524. PubMed ID: 22542050
[No Abstract] [Full Text] [Related]
9. Infliximab: in ankylosing spondylitis.
Robinson DM; Keating GM
Drugs; 2005; 65(9):1283-91; discussion 1292-4. PubMed ID: 15916451
[TBL] [Abstract][Full Text] [Related]
10. Infliximab for the treatment of ankylosing spondylitis.
Rudwaleit M; Sieper J
Expert Opin Biol Ther; 2005 Aug; 5(8):1095-109. PubMed ID: 16050786
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.
Braun J; Baraliakos X; Golder W; Brandt J; Rudwaleit M; Listing J; Bollow M; Sieper J; Van Der Heijde D
Arthritis Rheum; 2003 Apr; 48(4):1126-36. PubMed ID: 12687557
[TBL] [Abstract][Full Text] [Related]
12. Infliximab in the treatment of active and severe ankylosing spondylitis.
Brandt J; Sieper J; Braun J
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S106-10. PubMed ID: 12463458
[TBL] [Abstract][Full Text] [Related]
13. Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis.
Marocchi E; Spadaro A; Giannakakis K; Priori R; Valesini G
Clin Exp Rheumatol; 2010; 28(3):440. PubMed ID: 20576230
[No Abstract] [Full Text] [Related]
14. Efficacy of infliximab (Remicade) in the treatment of spondyloarthropathies. two case reports.
Kaiser MJ; Sany J
Joint Bone Spine; 2001 Dec; 68(6):525-7. PubMed ID: 11808993
[No Abstract] [Full Text] [Related]
15. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.
Braun J; Brandt J; Listing J; Zink A; Alten R; Golder W; Gromnica-Ihle E; Kellner H; Krause A; Schneider M; Sörensen H; Zeidler H; Thriene W; Sieper J
Lancet; 2002 Apr; 359(9313):1187-93. PubMed ID: 11955536
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab.
Conti F; Priori R; Chimenti MS; Coari G; Annovazzi A; Valesini G; Signore A
Arthritis Rheum; 2005 Apr; 52(4):1224-6. PubMed ID: 15818709
[TBL] [Abstract][Full Text] [Related]
17. Etanercept: new indication. For ankylosing spondylitis: another option.
Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
[TBL] [Abstract][Full Text] [Related]
18. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
Braun J; Baraliakos X; Brandt J; Listing J; Zink A; Alten R; Burmester G; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Sieper J
Rheumatology (Oxford); 2005 May; 44(5):670-6. PubMed ID: 15757965
[TBL] [Abstract][Full Text] [Related]
19. Intraarticular injection of infliximab.
Sakellariou GT; Kakavouli G; Chatzigiannis I
J Rheumatol; 2006 Sep; 33(9):1912-3; author reply 1913. PubMed ID: 16960955
[No Abstract] [Full Text] [Related]
20. Treatment of ankylosing spondylitis with infliximab.
Boeger CA; Wittwer H; Schattenkirchner M; Kellner H; Kellner W
Ann Rheum Dis; 2001 Dec; 60(12):1159-60. PubMed ID: 11760727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
